Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
3 Leser
Artikel bewerten:
(0)

Medical Laboratory Services Strategies, Trends and Forecasts 2015 to 2019 - Exciting Technical Developments Especially in the Area of Molecular Diagnostics and Pharmacogenics

DUBLIN, Nov. 18, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/mjhbvs/medical) has announced the addition of the "Medical Laboratory Services Strategies, Trends and Forecasts 2015 to 2019 - Global Version" report to their offering.

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • changing demographics
  • emerging economies and global prosperity
  • biotechnology advances in genetics
  • pathogen evolution
  • climate change
  • globalization
  • automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

"Medical Laboratory Services Strategies, Trends and Forecasts 2015 to 2019 - Global Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

Key Topics Covered:

1. Introduction and Market Definition

2. Market Overview

3. Market Trends

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments

5. Country Market Sizes - North America

6. Country Markets - Europe

7. Country Markets - Asia Pacific

8. Country Markets - Latin America, Africa & The Middle East

9. Global Market Summary

10. The Future of the Clinical Laboratory

Companies Mentioned

  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories, Inc.
  • Alere Inc
  • American Pathology Partners, Inc.
  • ARUP Laboratories, Inc.
  • Ascend Clinical, LLC
  • Aurora Diagnostics, LLC
  • Biomnis (France)
  • Bio-Reference Laboratories, Inc.
  • Bioscientia Institut fuer Medizinische Diagnostik GmbH
  • BP Lab
  • Caris Life Sciences, Inc.
  • Centrex Clinical Laboratories, Inc.
  • Clarient, Inc.
  • Claymon Biomnis Laboratories Ltd.
  • Clinical Reference Laboratory, Inc.
  • Clongen Laboratories LLC
  • CompuNet Clinical Laboratories, LLC
  • Diagnósticos da América (DASA)
  • DL Reference Laboratory
  • Enzo Biochem, Inc.
  • Exagen Diagnostics, Inc.
  • Genomic Health, Inc.
  • Genzyme Corporation
  • Gribbles Pathology
  • Integrated Regional Laboratories, Inc.
  • Kingmed Diagnostics
  • Laboratory Corporation of America
  • Lifelabs Medical Laboratory Services
  • Medicus Phillipines Inc.
  • MEDTOX Scientific, Inc.
  • Mid America Clinical Laboratories, LLC
  • Myriad Genetics, Inc.

For more information visit http://www.researchandmarkets.com/research/mjhbvs/medical

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.